An investigation on behalf of investors, who currently hold shares of LifePoint Health, Inc. (NASDAQ: LPNT), was announced concerning whether the takeover of LifePoint Health, Inc. is unfair to NASDAQ: LPNT stockholders.

The investigation by a law firm concerns whether certain officers and directors of LifePoint Health, Inc. breached their fiduciary duties owed to NASDAQ: LPNT investors in connection with the proposed acquisition.

Brentwood, TN based LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States.
On July 23, 2018, LifePoint Health, Inc. (NASDAQ: LPNT) and RCCH HealthCare Partners, which is owned by certain funds managed by affiliates of Apollo Global Management, LLC (NYSE: APO) (together with its consolidated subsidiaries, Apollo), announced that they have entered into an agreement to merge. Upon closing of the transaction, LifePoint shareholders will receive $65.00 per share in cash for each share of LifePoint common stock they own, resulting in a LifePoint enterprise value of approximately $5.6 billion, including $2.9 billion of net debt and minority interest.

However, the investigation concerns whether the offer is unfair to NASDAQ: LPNT stockholders. More specifically, the investigation concerns whether the LifePoint Health Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.